stoxline Quote Chart Rank Option Currency Glossary
  
ResMed Inc. (RMD)
204.84  5.06 (2.53%)    07-12 13:00
Open: 200.98
High: 206.84
Volume: 326,572
  
Pre. Close: 199.78
Low: 200.5
Market Cap: 30,092(M)
Technical analysis
2024-07-12 12:52:58 PM
Short term     
Mid term     
Targets 6-month :  251.08 1-year :  293.26
Resists First :  214.97 Second :  251.08
Pivot price 192.11
Supports First :  193 Second :  179.41
MAs MA(5) :  195.99 MA(20) :  197.08
MA(100) :  197.63 MA(250) :  179.27
MACD MACD :  -2.8 Signal :  -4.2
%K %D K(14,3) :  55.7 D(3) :  44
RSI RSI(14): 56.2
52-week High :  229.97 Low :  132.24
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ RMD ] has closed below upper band by 2.8%. Bollinger Bands are 3.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 200.53 - 201.3 201.3 - 202.18
Low: 192.91 - 193.73 193.73 - 194.68
Close: 198.22 - 199.57 199.57 - 201.11
Company Description

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Headline News

Fri, 12 Jul 2024
ResMed (NYSE:RMD) vs. GBS (NYSE:GBS) Critical Comparison - Defense World

Thu, 11 Jul 2024
ResMed Inc. stock rises Thursday, outperforms market - MarketWatch

Thu, 11 Jul 2024
Mediolanum International Funds Ltd Acquires New Position in ResMed Inc. (NYSE:RMD) - MarketBeat

Thu, 11 Jul 2024
Here's Why ResMed (RMD) is a Strong Growth Stock - Yahoo Finance Australia

Thu, 11 Jul 2024
Mutual of America Capital Management LLC Decreases Stock Position in ResMed Inc. (NYSE:RMD) - Defense World

Thu, 11 Jul 2024
Norden Group LLC Buys 1,190 Shares of ResMed Inc. (NYSE:RMD) - Defense World

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Shares Out 147 (M)
Shares Float 146 (M)
Held by Insiders 0.7 (%)
Held by Institutions 58.1 (%)
Shares Short 8,240 (K)
Shares Short P.Month 10,210 (K)
Stock Financials
EPS 6.5
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 31.52
Profit Margin 20.9 %
Operating Margin 31.2 %
Return on Assets (ttm) 11.9 %
Return on Equity (ttm) 22.3 %
Qtrly Rev. Growth 7.1 %
Gross Profit (p.s.) 0
Sales Per Share 31.17
EBITDA (p.s.) 9.8
Qtrly Earnings Growth 29.1 %
Operating Cash Flow 1,200 (M)
Levered Free Cash Flow 956 (M)
Stock Valuations
PE Ratio 31.47
PEG Ratio 1.8
Price to Book value 6.49
Price to Sales 6.56
Price to Cash Flow 25.04
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android